Clinical Trial Update: Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates [Phase 3]

View source ↗

Summary

A phase 3 trial comparing SMOFlipid lipid emulsion with a soy-based lipid for prevention of cholestasis in surgical neonates; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis of Parenteral Nutrition

Drugs mentioned

• Intralipid (intravenous lipid emulsion)
• SMOFLIPID

Snippet

Sponsor: Indiana University | Conditions: Cholestasis of Parenteral Nutrition | Phase 3 | Status: COMPLETED | Results posted: 2022-08-26